LabCorp: Prasanth Reddy, Robert Phillips

Laboratory Corporation of America has appointed Prasanth Reddy its SVP and enterprise oncology head of the firm's enterprise oncology unit, and Robert Phillips its VP and head of enterprise oncology science. The enterprise oncology unit will leverage LabCorp's drug development and diagnostics businesses to personalize cancer treatments for patients, the Burlington, North Carolina-based company said. Reddy was most recently VP of medical affairs at Foundation Medicine. Before that, he developed oncology service line treatment pathways at the Adventist Health System. Phillips joins LabCorp from Daiichi-Sankyo where he was VP and head of translational science and oversaw that firm's companion diagnostics efforts. He also was VP and head of precision medicine at Pfizer and was head of precision medicine at Regeneron Pharmaceuticals where he also founded the Regeneron Genetics Center.